Introduction {#s1}
============

Gastric cancer (GC) is now a leading cause of cancer-related morbidity, causing 9.7% of all cancer-related mortality around the world \[[@R01]\]. Almost 1 million new cases of stomach cancer were estimated to have occurred in 2012 (952,000 cases, 6.8% of the total), making it the fifth most common malignancy in the world, after cancers of the lung, breast, colorectum and prostate \[[@R02]\]. More than 70% of cases (677,000 cases) occur in developing countries (456,000 in men, 221,000 in women), and half the world total occurs in Eastern Asia (mainly in China) \[[@R02]\].Though Bangladesh is lacking a population-based statistics or national cancer registry for cancers; there are very few hospital-based statistics. According to the reports from the national guideline on GC management it is ranking as the fifth most common cancer and the third most common among the males. From the unpublished data across the country from different medical institutions it has been estimated that GC possesses the second position after lung cancer in males \[[@R03]\].

GC may be caused by environmental or lifestyle risks, host genetic polymorphisms, as well as ageing \[[@R04]\]. Many laboratory studies have pointed to roles for carcinogenic substances, including amine pyrolysate products and nitrosamines. A probable risk factor for stomach cancer is salt or salty foods, which act synergistically with *Helicobacter pylori* (*H. Pylori*) infection in the development of stomach cancer in experimental animals and humans \[[@R05]\]. Some risk factors are described in the literature: smoke is highlighted by the International Agency for Research on Cancer (IARC) \[[@R06]\]; *H. pylori* also labeled as an important factor for GC \[[@R07]-[@R9]\]. So it is now almost a settled issue that interaction among environmental factors, host genetic polymorphism and bacterial virulence collectively influence the clinical outcome of *H. pylori* infections \[[@R10], [@R11]\].

Numerous cytogenetic and molecular genetic studies reached to a common consensus that oncogene over expression, suppressor, mutator, methylator pathway hypotheses, and mismatched DNA repair, but exact molecular mechanisms of GC development remain elusive \[[@R12], [@R13]\].

The *TP53* is a tumor suppressor gene encodes a main regulator of cell growth and division. Studies showed that mutations in *TP53* are present in a range of 40-70% of early and advanced GCs, and inactivation of *TP53* resulting from loss of heterozygosity (LOH) is found in 60-70% of intestinal-type GCs. All collectively exponentiate this gene among the most frequently mutated genes in cancers \[[@R14]\]. Still studies are needed to settle the issue regarding the prevalence of *TP53* mutations and its relationship to clinicopathological features of GC \[[@R13], [@R15]\]. Frequent *p53* mutation has been shown in many human cancers; thus, this gene has been associated with carcinogenesis in humans. Gastric mucosal integrity is maintained by apoptosis balanced with cell proliferation. This balance of epithelial cell turnover is altered in the gastric mucosa of patients with GC. With regard to apoptosis, many studies have shown an increased expression and mutation of *p53* in *H. pylori* infected gastric mucosa. Therefore, the alteration of the *p53* gene is recognized to play a role in gastric carcinogenesis in subjects infected with *H. pylori* \[[@R16], [@R17]\].

In Bangladesh though stomach cancer is a leading cancer and also an important cause for cancer-related death, we have yet to find environmental, molecular and important risk factors. So far, we don't have any in depth or molecular study. Like in other developing countries *H. pylori* infection is also prevalent in Bangladesh. In a recent study on dyspeptic patients 67% of the subjects showed evidences for *H. pylori* infection in gastric biopsy samples taken by endoscopy \[[@R18]\]. This study was aimed to identify the status of *p53* mutation, to find its association with *H. pylori* infection and other clinicopathological and environmental factors in GC patients.

Materials and Methods {#s2}
=====================

This was a cross-sectional study carried out from January 2015 to December 2016 in the Department of Surgical Oncology, National Institute of Cancer Research and Hospital, Mohakhali, Dhaka, Bangladesh.

Patient selection {#s2a}
-----------------

After endoscopic diagnosis of the stomach adenocarcinoma, the patients who were preliminarily selected for surgical candidates were admitted for surgical intervention. Diagnostic workup was completed by routine hematological tests, investigations for general anesthesia, ultrasonography abdomen and in selected cases computed tomography (CT) scan of abdomen. Patient was randomly assigned as every alternate patient was taken into the study when they were finally selected for surgery. Surgeons were unaware of the subjects. Informed consent for surgery and study were taken from each patient. Approval was taken from the Institutions' Ethical Committee. For *H. pylori* antibody laboratory facilities were taken from the Department of Biochemistry Bangabandhu Sk Mujib Medical University, Dhaka.

### Exclusion criteria {#s2a1}

Patients with GCs other than adenocarcinoma, preoperative chemotherapy, radiotherapy, other organ malignancy and those who were unwilling to take part in the study were exclude from the study.

Procedure {#s2b}
---------

### Tissue collection {#s2b1}

Normal and tumor tissues were extracted from the specimen immediately after resection. The specimen surface was washed with normal saline prior to fragment extraction to avoid DNA contamination. Areas of tissue extraction from the specimen were demarcated for routine pathologic examination. Only tissue fragments containing suspected tumor tissue were included for *p53* analysis. Normal areas were used as controls.

### DNA extraction and optimization {#s2b2}

Tissues were stored at -80 °C before DNA purification and extraction. After that tissue was sent to the Laboratory of Genetic Engineering and Biotechnology Department of Centre for Advance Research in Science (CARS), University of Dhaka, under a memorandum of understanding with Surgical Oncology Department for PCR, sequencing and analysis.

In the laboratory tissues were incubated overnight at 55 °C in a buffer containing 100 mM TRIS-HCl (pH 8.5), 5 mM EDTA, 200 µg of proteinase K/mL, and 0.2% sodium dodecyl sulfate. The samples were cooled to room temperature, and DNA was precipitated with isopropanol and dissolved in 500 mL of buffer containing 10 mM TRIS (pH 8.2) and 1 mM EDTA.

### Primer sequences {#s2b3}

The overlapping primer sequences were used for amplification of *p53* gene.

### PCR amplification {#s2b4}

Primers were designed to amplify the coding region of *p53*. After PCR, 2% gel electrophoresis was done along with 1 kb DNA ladder to check the amplification of distinct PCR products. DNA was amplified in PCR machine in annealing temperature.

### Sequencing {#s2b5}

Purified PCR fragments were sequenced directly using a DNA sequencing kit according to Applied Biosystems from USA with Big Dye Terminators on an ABI3700 automated DNA sequencer for *p53* after proper primer designing exons 5 and 6 were used. Primer sequence was: *p53*-1 forward: 5'-ACAAGCAGTCACAGCACATGAC-3' and *p53*-1 reverse: 5' -TTCAGTAGAGAACGGGGTTTCACC-3'

### DNA sequence analysis {#s2b6}

The purified sequencing PCR products were analyzed by electrophoresis in the ABI-Prism 3130 Genetic Analyzer (Applied Biosystems, USA). The sequence patterns were observed and edited using Auto Assembler V 3.0 and BioEdit Sequence Alignment Editor V 7.0.9.0. *p53* polymorphisms were compared with the standard genome database of world population.

After finding the genetic changes it was matched with *H. pylori* status, clinicopathological profile like age, sex, tumor characters, types and location and grading of the tumor and some environmental factors like smoking, oral intake of extra salt.

The clinical data were obtained from history, clinical examination and each medical record of the patients. The status of *H. pylori* infection was determined by examining the preoperative sera.

Statistical analyses {#s2c}
--------------------

Result of the study was calculated and analyzed by standard statistical method and was presented in forms of tables and figures. Continuous data were expressed as mean ± standard deviation (SD). For analysis of data Statistical Package for the Social Sciences (SPSS) for Windows (IBM SPSS Statistics for Windows, version 22.0, Armonk, NY: IBM Corp.) software was used. To see the association between categorical variables Chi-squared test (or Fisher's exact test when applicable) was performed. Binomial logistic regression was used to explain the relationship between *p53* mutation and *H. pylori* infection, clinical and environmental factors in GC patients. A value of P \< 0.05 was considered statistically significant in all analyses.

Results {#s3}
=======

Patients {#s3a}
--------

Finally tissue samples from 71 patients could be examined for genetic tests. Selection of the patients in detail was shown in [Figure 1](#F1){ref-type="fig"}.The mean age of the patients was 52.96 years old with SD of 13.26, ranging from 26 to 87 years; younger group (n = 18) was categorized as 40 years or below; male: female ratio was 48:23. As generally in the public hospital people from a lower socioeconomic condition take their services, we can assume that majority are from poorer section of the society. Tumor staging T1-T3, and grading G1, G2, and G3 was shown in [Table 1](#T1){ref-type="table"}. Morphology was categorized as proliferative and ulceroproliferative ones, with the number is 62 (87.3%). *H. pylori* antibody analysis showed that among the 51 positive cases, 41 (80%) had mutated *p53* gene. The rest 11 cases with mutation were found among the 20 *H. pylori* non-infected cases. Chi-square test and Fisher's exact test showed that *H. pylori* infection has got strong association with the mutation (P = 0.033). The tumor was described as location, morphology, and size. It was seen that to find correlation with location of the tumor (cardia, midbody and antral), majority (\> 75%) of the lesion found in antral part (found no significant correlation with mutation), morphology of the tumor which was categorized as ulcerative, proliferative and ulceroproliferative didn't have any significant correlation with the mutation (P = 0.939), but the size of the tumor and lymph node involvement (N1 - N3) have significant correlation with the mutation (P = 0.05). Other factors like gender, smoking carried no impact on the mutation status. But extra salt intake in the regular diet had strong correlation with the mutation. Considering the age group, 18 patients were at or below 40 years of age, 17 of them had *p53* mutation (P = 0.015), which reflects a very strong association with age. The logistic regression was performed to ascertain the effects of age, gender, tumor status (T), grading, node status, smoking, and extra salt intake. The model explained 66.0% (Nagelkerke R^2^) of the variance gene mutation of GC and correctly classified 87.0% of cases.
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###### Factors Related to *p53* Mutation

  Factors                       Positive   Percentage   Negative   Percentage   Total   P value
  ----------------------------- ---------- ------------ ---------- ------------ ------- ---------
  Smoking                                                                               
    Smoker                      33         75.0%        11         25%          44      0.436
    Non smoker                  19         70.4%        8          29.6%        27      
  Age group                                                                             
    ≤ 40 yrs                    17         94.4%        1          5.6%         18      0.015
    ≥ 41 yrs                    35         66%          18         34%          43      
  Location of the tumor                                                                 
    Fundus                      7          77.8%        2          22.2%        9       0.790
    Body                        20         69%          9          31%          29      
    Antrum                      25         75.8%        8          24.2%        33      
  Extra salt intake                                                                     
    Yes                         41         80.39        10         19.60        51      0.033
    No                          11         55           9          45           20      
  Morphology of the tumor                                                               
    Ulcerative                  7          77.8         2          22.2%        9       0.939
    Proliferative               23         71.9%        9          28.1%        32      
    Ulceroproliferative         22         73.3%        8          26.7%        30      
  Tumor (T)                                                                             
    T1 - T3                     42         79.2%        11         20.8%        53      0.05
    T4                          10         55.6%        8          44.4%        18      
  Lymph node status (N)                                                                 
    N0                          26         83.9%        5          16.1%        31      0.05
    N1 - N3                     26         65.0%        14         35.0%        40      
  Metastasis (M)                                                                        
    M0                          47         73.4%        17         26.6%        64      .218
    M1                          5          83.3%        1          16.7%        6       
  Gender                                                                                
    Male                        37         77.1%        11         22.9%        48      0.219
    Female                      15         65.2%        8          34.8%        23      
  *H. pylori*                                                                           
    Positive                    41         78.8 %       10         19.2%        51      0.043
    Negative                    11         21.15        9          17.3%        20      
  Grading                                                                               
    Well differentiated         3          5.76         0                       3       0.247
    Moderately differentiated   20         38.46        11         21.15        31      
    Poorly differentiated       29         55.76        8          15.38        37      

The Wald test ("Wald" column) is used to determine statistical significance for each of the independent variables. The statistical significance of the test is found in the "Sig" column. From these results we can see that morphology (2) (P = 0.037), Stage T (1) (P = 0.004), *H. pylori* (1) (P = 0.012), grading (P = 0.031), grading (2) (P = 0.008) and age group (P = 0.006) added significantly to the model/prediction, but other independent variables did not add significantly to the model.

*H. pylori*-infected cases, younger patients, T4 diseases, body tumors had more chances of association with *p53* mutation, which was shown in [Tables 2](#T2){ref-type="table"}-[](#T3){ref-type="table"}[](#T4){ref-type="table"}[5](#T5){ref-type="table"}.

###### Logistic Regression Analysis of *H. pylori* and *p53* Mutation (Dependent Variable: *p53*, Sample Size = 71)

  Model summary                       
  --------------- ----------- ------- -------
  1               55.798^a^   0.313   0.456

^a^Estimation terminated at iteration number 6 because parameter estimates changed by less than 0.001.

###### Variables in the Equation

                Coefficient   SE      Wald    DF   Sig     Exp(B)
  ------------- ------------- ------- ------- ---- ------- --------
  Smoking       -0.235        0.883   0.071   1    0.790   0.790
  Location      -0.210        0.508   0.171   1    0.679   0.810
  Extra salt    1.149         0.845   1.848   1    0.174   3.155
  Morphology    -0.257        0.526   0.238   1    0.625   0.773
  Stage T       1.822         0.863   4.454   1    0.035   6.184
  Stage N       1.150         0.872   1.738   1    0.187   3.159
  Stage M       -0.610        1.663   0.135   1    0.714   0.543
  Sex           0.616         0.807   0.583   1    0.445   1.851
  *H. pylori*   2.060         0.775   7.062   1    0.008   7.848
  Grading       -0.837        0.609   1.890   1    0.169   0.433
  Age group     2.693         1.330   4.103   1    0.043   14.780
  Constant      -11.258       4.223   7.107   1    0.008   0.000

SE: standard error; DF: degree of freedom; Sig: significance level; Exp (B): exponentiation of the B coefficient, which is an odds ratio.

###### Contribution of Each Independent Variable to the Model and Its Statistical Significance

                       B         SE          Wald    DF   Sig     Exp (B)        95% CI for Exp (B)   
  -------------------- --------- ----------- ------- ---- ------- -------------- -------------------- ---------
  Step 1^a^                                                                                           
    Smoking (1)        0.331     1.066       0.096   1    0.756   1.392          0.172                11.248
    Location                                 3.610   2    0.164                                       
      Location (1)     -0.185    2.100       0.008   1    0.930   0.831          0.014                50.999
      Location (2)     2.196     1.191       3.397   1    0.05    8.985          0.870                92.801
    Extra salt (1)     -1.596    1.077       2.198   1    0.138   0.203          0.025                1.672
    Morphology                               4.340   2    0.114                                       
      Morphology (1)   1.464     1.443       1.029   1    0.310   4.324          0.256                73.155
      Morphology (2)   2.358     1.132       4.340   1    0.037   10.573         1.150                97.220
    Stage T (1)        -4.326    1.501       8.307   1    0.004   0.013          0.001                0.250
    Stage N (1)        -1.590    1.108       2.058   1    0.151   0.204          0.023                1.790
    Stage M                                  0.000   2    1.000                                       
      Stage M (1)      18.106    40192.971   0.000   1    1.000   73013299.578   0.000                
      Stage M (2)      -0.001    1.730       0.000   1    1.000   0.999          0.034                29.659
    Sex (1)            -0.529    0.999       0.280   1    0.597   0.589          0.083                4.177
    *H. pylori* (1)    -2.678    1.062       6.359   1    0.012   0.069          0.009                0.551
    Grading                                  6.980   2    0.031                                       
      Grading (1)      -19.315   21121.983   0.000   1    0.999   0.000          0.000                
      Grading (2)      3.850     1.457       6.980   1    0.008   46.973         2.701                816.839
    Age group          -5.221    1.907       7.496   1    0.006   0.005          0.000                0.227
    Constant           2.308     1.974       1.367   1    0.242   10.053                              

^a^Variable (s) entered on step 1: smoking, location, extra salt, morphology, stage T, stage N, stage M, sex, *H. pylori*, grading, and age. SE: standard error; DF: degree of freedom; Sig: significance level; Exp (B): exponentiation of the B coefficient, which is an odds ratio.

###### Odd Ratio of *p53* Mutation in *H. pylori-*Infected Patients

                   *H. pylori*   Odd ratio   Interpretation   
  ---------------- ------------- ----------- ---------------- ---------------------------------------------------------------------------------------------------------------------------------
  *p53* positive   41            11          3.35             People having positive *H. pylori* have 3.35 times the chance of *p53* mutation compared to people having negative *H. pylori*.

Discussion {#s4}
==========

In this study tissue sample from gastrectomy specimen was taken for *p53* gene mutation, blood sample was taken for investigation about *H. pylori* status. Samples were sent to two different laboratories. Finally results of the two tests were matched to find the linkages between *p53* gene mutation with *H. pylori* positivity. We also investigated the correlation of *p53* mutation with age, sex, tumor profile and daily habits like smoking and extra salt intake in the daily diets.

*H. pylori* infection and *p53* mutation {#s4a}
----------------------------------------

On gene analysis it was seen that among the *H. pylori* infected cases over 80% have alteration of *p53* in the tested gene in the current series, despite of using only exons 5 and 6. Chi-square and regression analysis shows that they have strong and significant association. In Bangladesh there was no previous study in this field. Around the globe there are different studies covering this area. It has been suggested that *H. pylori* can initiate GC through *p53* tumor suppressor mutation \[[@R19]\]. The *p53* abnormalities have been assessed in several studies of GC associated with *H. pylori* infection \[[@R20], [@R21]\], but controversy still remains. Still it has been suggested that *H. pylori* initiates GC through *p53* tumor suppressor mutation \[[@R19]\]. Other study concludes that *H. pylori* infection affects *p53* expression in tumor tissue of GC sections. The average *p53* expression was significantly higher in tumor than in normal tissues. Overall, the detection of *p53* in tumor tissue of resected GC sections provided additional supportive evidence for the effect of *H. pylori* on its expression \[[@R22], [@R23]\] even in the form of chronic gastritis which was labeled as preneoplastic to neoplastic changes \[[@R22], [@R24]\].

Age and sex {#s4b}
-----------

On analysis of the altered *p53* gene in this study, it was found that it had a strong correlation with age of the patients. The age group of this study was categorized as 40 years (younger) or below and 41 years or above; nearly all of the younger patients had gene mutation. It was a common fact that ageing and carcinogenesis runs together. Among many cancers it is observed that gastric and colorectal ones also occur more often in the elderly. Studies show that GC rarely occurs before the age of 40 years, with aging its incidence increases, and getting the peak in the seventh decade \[[@R25], [@R26]\]. Reasons may be that long-term exposure of cancer-causing agents has been offered for the age-dependent rise in malignancies \[[@R27]\]. Carcinogenesis, which is a multistep process, results from the accumulation of mutations during progression from normal epithelium to carcinoma \[[@R28]\]. Their view expressed that in humans, the incidence of mutations of several tumor suppressor genes, specifically *APC, DCC,* and *p53* in the gastric mucosa, is higher in older subjects \[[@R25]\]. But other study found *p53* mutation in younger subjects of proximal stomach cancers \[[@R29]\]. In this study it is seen that younger patients are more prone to have gene mutation. Regarding to gender distribution, males are prone to develop GC, which matches with this study \[[@R25], [@R26]\]; but it is not found to have significant mutation in the current study.

Tumor profile {#s4c}
-------------

In this study, we tried to find correlation of *p53* mutation with the different domains of the tumor factor like morphology, location, extension and grading. Though most of the tumors are located within mid body and antrum it does not have any significant correlation. On the other hand extension of the tumor, lymph node involvement had significant correlation with the genetic mutation. Though there is limited study on the clinical relevance with gene alteration, it has been shown in different previous studies that it is associated with advanced stage, higher grade \[[@R30], [@R31]\], and some study had found negative association with lymph node status, grading and metastasis \[[@R29]\].

Environmental factors {#s4d}
---------------------

The first is extra salt intake. It has been seen that in some areas of Bangladesh people are prone to have more GC in their vicinity. On enquiry and also in the series some of the patients have routine habit to consume extra salt in their daily meals; on analysis it was found that it has strong correlation with *p53* mutation. A prospective study from a Japanese population suggests that high dietary salt intake (\> 10 g per day) is a significant risk factor for GC, and this association was found to be stronger in the presence of *H. pylori* infection with atrophic gastritis \[[@R32], [@R33]\].

Smoking is also a common habit among the male in this part of the world. Since GC is a male dominant disease it is likely that smoking may be a predisposing risk factor of the disease. Though there were a good number of smoker patients (63.4%), 75% had *p53* mutation in our series; it doesn't have significant correlation on regression analysis and Chi-square test. Although the role of smoking in causing several other cancers has long been established, it was not until 2002 that the International Agency for Research on Cancer concluded that there was "sufficient" evidence of causality between smoking and GC \[[@R34]\]. In a large population-based study in Europe (EPIC), 17.6% of GC cases were related to smoking \[[@R35]\]. Though the exact mechanisms are unclear, studies predicted that oxygen radicals and increased apoptosis associated with smoking induces precancerous changes in the gastric epithelium, further promoting the progression of carcinogenesis \[[@R36]\]. There is limited study on association of *p53* mutation with smoking. But there are few studies on *p53* and cancer. In a larger Saudi study they found no association of *p53* mutation among the smokers \[[@R37]\]. A statistically significant association was found between *p53* mutations and exposure to tobacco smoke (P = 0.001), which was the only variable significantly associated with *p53* mutations in a multivariate model \[[@R38]\].

In Bangladesh, GC incidence is in rising trend. Regarding *H. pylori* infection, different studies directed that in the last 20 years infection is in down trend \[[@R39]\]. In a case control study \[[@R40]\] to see relationship of GC with *H. pylori* infection, it is well established that there is also a close association of *H. pylori* infection with GC. We have yet to find any molecular study. Within this limited facility we could finally explore the status of *p53* alteration which is remarkably present in our patients and have strong association with *H. pylori* infection.

Conclusions {#s4e}
-----------

As Bangladesh still being a member of the low economic country in the globe, it has to bear big burden and carry devastating tales of the GC patients. The disease has a higher mortality and poor patients have to bear intolerable sufferings in the terminal stages when the standard therapeutic measures cannot be offered. On the other hand it is established that the disease is an inflammation-associated cancer, and in addition to the inflammation, the *H. pylori* organism itself can directly cause genetic instability, which is also influenced by environmental factors and some host factors. The current study found genetic alteration in *H. pylori-*infected patients which is synergistically affected by clinical and environmental factors. Cure of *H. pylori* prior to development of different steps of carcinogenesis will essentially prevent the development of GC. It seems to be the fact that the status of *p53* in the tumor cannot inform about the stage of the tumor but assessing *p53* status may be beneficial in early detection and monitoring of tumor relapse, by detecting p53 antibodies and mutant *p53* DNA. Furthermore, analysis of *p53* status can serve as a tool in the prediction of effective therapeutic regimens, whereas *p53* itself particularly mutant *p53*, may represent targets for cancer therapy \[[@R41]\]. Additional molecular studies in a larger scale to delineate exact molecular mechanisms linking the relationship with environmental, demographic and host factors are needed. A large scale nation-wide anti-*H. pylori* measures in the community particularly in the low income section of people may bring a drastic declining change for the future GC incidences.
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